Home / Business and Economy / Africa's Pharma Future: Local Vaccine Push Gains Steam
Africa's Pharma Future: Local Vaccine Push Gains Steam
12 May
Summary
- Africa CDC in talks for long-term vaccine demand.
- Goal is to cut import reliance and boost local manufacturing.
- Aspen Pharmacare is a key partner in these discussions.
Africa's leading public health agency, the Africa Centres for Disease Control and Prevention (Africa CDC), is in advanced discussions with Aspen Pharmacare Holdings Ltd. The primary objective is to guarantee sustained demand for vaccines produced within Africa.
This crucial collaboration is part of a broader continental strategy to decrease reliance on imported vaccines. By fostering local manufacturing, Africa aims to build greater self-sufficiency and resilience in its public health infrastructure.
The ongoing talks with Aspen Pharmacare signal a significant step towards achieving these ambitious goals. Strengthening the continent's capacity to produce its own vaccines is a key priority for regional health security.
